Benzinga | Jul 29, 2021 07:25AM EDT

AstraZeneca Looking At Potential Options for COVID-19 Vaccine Business: Reuters

* AstraZeneca plc (NASDAQ:AZN) is reportedly exploring its options for the future of its COVID-19 vaccine business.

* The Company expects clarity on the matter by the end of 2021.

* "We are exploring different options," Ruud Dobber, executive vice president and president of BioPharmaceuticals Business Unit, told Reuters about the vaccines business.

* The Company generated around $894 million from COVID-19 vax sales in Q2.

* Price Action: AZN shares are up 1.6% at $57.70 during the premarket session on the last check Thursday.

* Image by Wilfried Pohnke from Pixabay